Abbott India (BOM:500488) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Abbott India FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Abbott India's Free Cash Flow for the three months ended in Mar. 2024 was ₹0 Mil. Abbott India's Revenue for the three months ended in Mar. 2024 was ₹14,386 Mil. Therefore, Abbott India's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Abbott India's current FCF Yield % is 2.12%.

The historical rank and industry rank for Abbott India's FCF Margin % or its related term are showing as below:

BOM:500488' s FCF Margin % Range Over the Past 10 Years
Min: 3.89 Med: 14.08 Max: 19.91
Current: 19.91

During the past 13 years, the highest FCF Margin % of Abbott India was 19.91%. The lowest was 3.89%. And the median was 14.08%.

BOM:500488's FCF Margin % is ranked better than
89.55% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.195 vs BOM:500488: 19.91

Abbott India FCF Margin % Historical Data

The historical data trend for Abbott India's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India FCF Margin % Chart

Abbott India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

14.92

16.33

18.40

16.07

19.91

Abbott India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Abbott India's FCF Margin %

For the Drug Manufacturers - General subindustry, Abbott India's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott India's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Abbott India's FCF Margin % falls into.

Abbott India FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Abbott India's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	11644.8	/	58489.1
	=	19.91 %

Abbott India's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	14386.3
	=	0.00 %

Abbott India FCF Margin % Related Terms

Thank you for viewing the detailed overview of Abbott India's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott India (BOM:500488) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

ABBOTINDIA:India

Address

15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.abbott.co.in

Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines